Literature DB >> 19575464

Stereoselective transport and uptake of propranolol across human intestinal Caco-2 cell monolayers.

Yi Wang1, Jiang Cao, Xiaodan Wang, Su Zeng.   

Abstract

The transport and uptake of individual propranolol (PPL) enantiomers were studied in human intestinal Caco-2 cell monolayers, and a reversed-phase HPLC-UV assay was used for quantitative analysis. S-PPL and R-PPL across Caco-2 cell monolayers was determined in the concentrations range of 10-500 microM in both apical (AP) to basolateral (BL) and BL to AP directions. S-PPL exhibited greater permeability than R-PPL in the AP to BL direction, whereas in the BL to AP direction S-enantiomer transported less than R-enantiomer. Uptake of R-PPL was significantly higher than that of S-PPL either from AP side or from BL side. The statistically significant differences in uptake were observed at the concentrations range from 10 to 50 microM. Furthermore, the apparent Michaelis constant (K(m)) and maximal velocity (V(max)) also showed significant difference between the two enantiomers. Moreover, the AP to BL transport of PPL enantiomer was markedly decreased by lowering the pH of the apical side but it did not affect the stereoselectivity of PPL across Caco-2 cell monolayers. The transport and uptake of PPL in the BL to AP direction was not influenced by several protein inhibitors. The results suggest that PPL enantiomers showed stereoselective transport and uptake across the Caco-2 cell monolayers. A special transport mechanism capable of directing the PPL enantiomers might be present in the Caco-2 monolayers. 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19575464     DOI: 10.1002/chir.20753

Source DB:  PubMed          Journal:  Chirality        ISSN: 0899-0042            Impact factor:   2.437


  8 in total

1.  pH Dependent but not P-gp Dependent Bidirectional Transport Study of S-propranolol: The Importance of Passive Diffusion.

Authors:  Yi Zheng; Leslie Z Benet; Hideaki Okochi; Xijing Chen
Journal:  Pharm Res       Date:  2015-02-19       Impact factor: 4.200

2.  A primary fish gill cell culture model to assess pharmaceutical uptake and efflux: evidence for passive and facilitated transport.

Authors:  Lucy C Stott; Sabine Schnell; Christer Hogstrand; Stewart F Owen; Nic R Bury
Journal:  Aquat Toxicol       Date:  2014-12-16       Impact factor: 4.964

Review 3.  Stereoselective binding of chiral drugs to plasma proteins.

Authors:  Qi Shen; Lu Wang; Hui Zhou; Hui-di Jiang; Lu-shan Yu; Su Zeng
Journal:  Acta Pharmacol Sin       Date:  2013-07-15       Impact factor: 6.150

Review 4.  How drugs get into cells: tested and testable predictions to help discriminate between transporter-mediated uptake and lipoidal bilayer diffusion.

Authors:  Douglas B Kell; Stephen G Oliver
Journal:  Front Pharmacol       Date:  2014-10-31       Impact factor: 5.810

Review 5.  Significance and challenges of stereoselectivity assessing methods in drug metabolism.

Authors:  Zhuowei Shen; Chuang Lv; Su Zeng
Journal:  J Pharm Anal       Date:  2015-12-21

6.  Development of Physiologically Based Pharmacokinetic Model for Orally Administered Fexuprazan in Humans.

Authors:  Yoo-Seong Jeong; Min-Soo Kim; Nora Lee; Areum Lee; Yoon-Jee Chae; Suk-Jae Chung; Kyeong-Ryoon Lee
Journal:  Pharmaceutics       Date:  2021-05-29       Impact factor: 6.321

7.  The apparent permeabilities of Caco-2 cells to marketed drugs: magnitude, and independence from both biophysical properties and endogenite similarities.

Authors:  Steve O'Hagan; Douglas B Kell
Journal:  PeerJ       Date:  2015-11-17       Impact factor: 2.984

Review 8.  Fitting Transporter Activities to Cellular Drug Concentrations and Fluxes: Why the Bumblebee Can Fly.

Authors:  Pedro Mendes; Stephen G Oliver; Douglas B Kell
Journal:  Trends Pharmacol Sci       Date:  2015-11-01       Impact factor: 14.819

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.